SynthesisExploration of targeted anti-tumor therapy2025

A systematic review and meta-analysis of phase III randomized controlled trials to assess the risk of pneumonia, URTIs, and VTE in multiple myeloma patients treated with isatuximab.

Daniel Thomas Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.